Patients with Residual Stage Angle-Closure Glaucoma may experience symptoms such as blurred vision, halos around lights, eye pain, and headaches. However, in many cases, the condition can be asymptomatic, especially in its early stages. As the disease progresses, patients may notice a gradual loss of peripheral vision, which can eventually lead to tunnel vision.

Diagnosing Residual Stage Angle-Closure Glaucoma involves a comprehensive eye examination. Key tests include:

• Tonometry: Measures the intraocular pressure.
• Gonioscopy: Assesses the drainage angle of the eye.
• Optical Coherence Tomography (OCT): Provides detailed images of the optic nerve and retina.
• Visual Field Test: Evaluates peripheral vision loss.
• Slit Lamp Examination: Allows for a detailed view of the eye's structures.

These tests help determine the extent of angle closure and optic nerve damage.

The primary goal of treatment is to lower intraocular pressure and prevent further optic nerve damage. Options include:

• Medications: Eye drops or oral medications to reduce IOP.
• Laser Therapy: Procedures like laser peripheral iridotomy or laser iridoplasty to open the drainage angle.
• Surgery: In some cases, surgical intervention may be necessary to create a new drainage pathway.

Regular monitoring and follow-up are crucial to adjust treatment as needed.

With early detection and appropriate management, the prognosis for Residual Stage Angle-Closure Glaucoma can be favorable. However, if left untreated, it can lead to significant vision loss and even blindness. Continuous monitoring and adherence to treatment are essential to preserve vision.

Residual Stage Angle-Closure Glaucoma typically develops from an acute angle-closure episode, where the drainage angle of the eye becomes suddenly blocked. Factors contributing to this condition include anatomical predispositions, such as a shallow anterior chamber, hyperopia (farsightedness), and age-related changes in the eye.

Angle-closure glaucoma is more prevalent in certain populations, particularly among older adults, women, and individuals of Asian descent. The residual stage is less common than the acute form but requires careful management to prevent progression.

In Residual Stage Angle-Closure Glaucoma, the drainage angle of the eye remains partially blocked, leading to increased intraocular pressure. This pressure can damage the optic nerve over time, resulting in vision loss. The condition is often associated with structural changes in the eye, such as a thickened lens or a narrow anterior chamber.

Preventive measures focus on early detection and management of risk factors. Regular eye examinations, especially for individuals at higher risk, can help identify angle-closure glaucoma before it progresses to the residual stage. Educating patients about symptoms and the importance of adherence to treatment can also aid in prevention.

Residual Stage Angle-Closure Glaucoma is a chronic eye condition resulting from a partially blocked drainage angle, leading to increased intraocular pressure and potential optic nerve damage. Early detection and appropriate management are crucial to prevent vision loss. Regular monitoring and treatment adjustments are essential for maintaining eye health.

If you have been diagnosed with Residual Stage Angle-Closure Glaucoma, it's important to follow your eye doctor's recommendations closely. This may include using prescribed eye drops, attending regular check-ups, and possibly undergoing laser therapy or surgery. Understanding your condition and adhering to treatment can help preserve your vision and maintain your quality of life.